NEW YORK (360Dx) – Biosynth and Ramot, the Tel Aviv University Business Engagement Center, announced this week that they have incorporated a joint venture called Nemis Technologies to jointly develop diagnostic kits and solutions for rapid pathogenic bacteria detection for food safety, water treatment, hospital, and clinical applications. The base technology, called AquaSpark, enables highly sensitive chemiluminescence probes for research and diagnostic applications, the partners said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.